Marr Consultancy

Andrew Marr to speak at Infotehna’s Pharmaceutical Conference : 23 May 2013

andrew — Thu, 07 Mar 2013 22:02:06 +0000

Andrew Marr will be speaking at Infotehna’s 15th Annual Pharmaceutical Conference in Brdo near Kranj, Slovenia on 23 May 2013 on the topic of XEVMPD and transition to IDMP.

More details on the conference and be found here.

Andrew Marr to chair a session at the DIA Regulatory Information Management meeting : 3-4 April 2013

andrew — Thu, 07 Mar 2013 21:22:24 +0000

Andrew Marr will be chairing a session on XEVMPD and IDMP at the forthcoming DIA Regulatory Information Management meeting to be held in Baltimore, Maryland on 3 and 4 April, 2013. The session speakers will be Vada Perkins (FDA), John Kiser (AbbVie) and William Mandarino (UCB).

More details of the conference can be found here.

Andrew Marr to speak at Informa’s Regulatory Information Management meeting : 24/25 April 2013

andrew — Thu, 07 Mar 2013 21:03:10 +0000

Andrew Marr will be speaking at the Regulatory Information Management meeting in Cologne, Germany being held 24-25 April 2013 on the subject of ‘A critical update on recent XEVMPD progress and developments’. Additionally, he will be co-leading an evening seminar entitled ‘ISO IDMP information and troubleshooting forum”.

More details can be found here.

Andrew Marr to speak on XEVMPD and IDMP at Product Life’s ‘Petit Déjeuner’ : 15 March 2013

andrew — Thu, 07 Mar 2013 20:45:01 +0000

Andrew Marr will be speaking at Product Life’s breakfast meeting in Paris on 15 March 2013 on the topic of ‘Transitioning from XEVMPD to IDMP : the challenges and opportunities’.

More details can be found here.

Andrew Marr to speak at Informa’s eCTD Conference : 27/28 February 2013

andrew — Tue, 06 Nov 2012 14:33:11 +0000

Andrew Marr will be speaking on the topic of XEVMPD and ISO IDMP at Informa’s eCTD Conference to be held in London on 27 & 28 February 2013.

Further information about the conference can be found here.

Andrew Marr to speak and be a panel member at DIA’s EDM and ERS/eCTD Conference : 9-11 October 2012

andrew — Fri, 24 Aug 2012 15:57:00 +0000

Andrew Marr will be present on the work of the IRISS IDMP Topic Group in a session of ‘Collaborative Opportunities’ and in a panel session on ‘EU and RoW Module 1′ at the DIA EDM and ERS/eCTD conference being held in Baltimore, Maryland on 9-11 October 2012. Details of the conference can be found here.

Andrew Marr to speak at Infotehna-hosted Webinar on Regulatory Information Management – 2 October 2012

andrew — Fri, 24 Aug 2012 15:46:54 +0000

Andrew Marr will be speaking at a webinar entitled ‘Regulatory Information Management : from R&D planning to XEVPRM and ISO IDMP’ hosted by Infotehna, in conjuction with Business Review Webinars, on 2 October 2012. Details of the content of the webinar and how to sign up can be found here.

Andrew Marr to speak at Lorenz UserBridge Conference 25-27 September 2012

andrew — Fri, 24 Aug 2012 14:57:23 +0000

Andrew Marr will be speaking on the latest developments with the XEVMPD at Lorenz’s annual UserBridge Conference being held in Dublin, Ireland from 25 to 27 September 2012.

Details of the conference and how to sign up can be found here.

Andrew Marr to speak at TOPRA CRED course on eCTD/Regulatory Information Management – 25 October 2012

andrew — Fri, 24 Aug 2012 14:49:43 +0000

As a Fellow of TOPRA, Andrew Marr is pleased to announce that he will be taking part in the TOPRA Continuing Regulatory Education and Development (CRED) course entitled ‘Regulatory Information Management: from R&D planning to Extended EudraVigilance Product Report Message (XEVPRM) and ISO IDMP’. The course is designed to offer a practical insight into the complex process of managing regulatory information in a global environment. The course will take place at the TOPRA Offices in London on 25 October 2012. Details of the course can be found here.

Andrew Marr assesses the changes and impacts of the revised XEVMPD guidance of 5 March 2012

andrew — Thu, 15 Mar 2012 14:31:35 +0000

Andrew Marr re-assesses the impact of the revised guidance on XEVMPD issued by EMA on 5 March 2012

EVMPD data are still required to be submitted to EMA for all authorised medicinal products in Europe by 2 July 2012 but the scope of the data required is reduced.

Click here to view the journal article. Journal Article

This article was published on 15 March 2012 in the on-line version of Scrip Regulatory Affairs.

If you are interested in purchasing a much more detailed assessment of the changes and their business impacts then please contact me for details.